- Home
- SNES vs COSM Comparison
SNES vs COSM Comparison
Compare SNES & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNES | COSM |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 16.1M |
| IPO Year | 2016 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SNES | COSM |
|---|---|---|
| Price | $2.57 | $0.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 50.4K | ★ 611.1K |
| Earning Date | 11-10-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,301,000.00 | ★ $59,792,819.00 |
| Revenue This Year | $41.52 | $28.14 |
| Revenue Next Year | $77.28 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 39.37 | 6.69 |
| 52 Week Low | $1.30 | $0.28 |
| 52 Week High | $6.24 | $1.32 |
Technical Indicators
Market Signals| Indicator | SNES | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 23.06 |
| Support Level | $2.70 | $0.44 |
| Resistance Level | $2.94 | $0.66 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 9.80 | 6.86 |
Price Performance
Historical ComparisonAbout SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.